Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)
CAPS Rating:
A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract.
RSS Headlines
Fool UK
Recs
This stock meets my criteria for a long-term buy: great management and a good price.